4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000144
Chief Medical Officer sold 2,595 shares at $19.03 ($49,383)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-10-22 | Sale | −2,595 | $19.03 | $49,383 | 217,958 | D |
| Open-market sales · 2,595 sh · avg $19.03 · $49,383 | |||||||
Loading xslF345X05/wk-form4_1761338306.xml…